ro 31-8220 has been researched along with Congenital Myotonic Dystrophy in 2 studies
Ro 31-8220: a protein kinase C inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ketley, A | 1 |
| Chen, CZ | 1 |
| Li, X | 1 |
| Arya, S | 1 |
| Robinson, TE | 1 |
| Granados-Riveron, J | 1 |
| Udosen, I | 1 |
| Morris, GE | 1 |
| Holt, I | 1 |
| Furling, D | 1 |
| Chaouch, S | 1 |
| Haworth, B | 1 |
| Southall, N | 1 |
| Shinn, P | 1 |
| Zheng, W | 1 |
| Austin, CP | 1 |
| Hayes, CJ | 1 |
| Brook, JD | 1 |
| Zhao, Y | 1 |
| Koebis, M | 1 |
| Suo, S | 1 |
| Ohno, S | 1 |
| Ishiura, S | 1 |
2 other studies available for ro 31-8220 and Congenital Myotonic Dystrophy
| Article | Year |
|---|---|
High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines.
Topics: Alternative Splicing; Animals; CELF1 Protein; Cell Nucleus; Cells, Cultured; Chromomycin A3; Disease | 2014 |
Regulation of the alternative splicing of sarcoplasmic reticulum Ca²⁺-ATPase1 (SERCA1) by phorbol 12-myristate 13-acetate (PMA) via a PKC pathway.
Topics: Alternative Splicing; Exons; HEK293 Cells; Humans; Indoles; Myotonic Dystrophy; Protein Kinase C; Pr | 2012 |